IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Caxton Corp

Q1 2025 Holdings

Filed 2025-05-15 | 12 holdings | $5.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Rezolute Inc(RZLT)COM NEW76200L309$3.8M1,318,96775.3%
Spdr Gold TR(GLD)GOLD SHS78463V107$374.1K1,2987.4%
Berkshire Hathaway Inc del(BRK/B)CL B NEW084670702$248.8K4674.9%
Mind Medicine Mindmed Inc(BRD1EUR)COM NEW60255C885$199.3K34,0733.9%
Bicara Therapeutics Inc(BCAX)COM055477103$142.6K10,9412.8%
Compass Therapeutics Inc(CMPX)COM20454B104$82.6K43,4651.6%
Lexeo Therapeutics Inc(LXEO)COM52886X107$61.9K17,8511.2%
Kyverna Therapeutics Inc(KYTX)COM501976104$44.4K22,9810.9%
Cardiff Oncology Inc(CRDF)COM14147L108$41.7K13,2870.8%
Inhibikase Therapeutics Inc(IKT)COM NEW45719W205$35.9K16,3930.7%
Adicet BIO Inc(TORCEUR)COM007002108$13.2K17,4880.3%
Context Therapeutics Inc(CNTX)COM21077P108$11.3K18,4030.2%